News for Pacific Edge Limited (PEB.NZ)

Pacific Edge is now targeting the opening of a NZ$5 million offer to eligible retail investors by way of a Share Purchase Plan (SPP) at the same NZ$0.10 cents per share offer price in July or early August 2025 (with the ability to accept oversubscriptions).

Pacific Edge also announces a NZ$20 million equity raising to capitalize on recent clinical and commercial milestones, grow in non-Medicare channels and regain Medicare coverage. The details of the capital raising are covered in a separate announcement ...

The major U.S. index futures are currently pointing to a lower open on Monday, with stocks likely to add to the steep losses posted during last Friday's session.

Asian markets declined heavily amidst fears of an extended pause by the Federal Reserve attributed to stronger-than-expected payrolls data from the U.S..

Disappointing guidance from tech giant Nvidia offered little cheer for Asian markets rattled by uncertainty over Bank of Japan's monetary policy plans, and less-than-expected stimulus measures from China.

The major U.S. index futures are currently pointing to initial strength on Wednesday, with stocks likely to see further upside after ending the previous session mostly higher.

Equity markets in Asia closed on a mixed note on Wednesday ahead of the much-anticipated earnings update from NVIDIA Corp..

The major U.S. index futures are currently pointing to a lower open on Tuesday, with stocks likely to move back to the downside following the rebound seen in the previous session.

Equity markets in Asia closed on a positive note on Tuesday amidst growing hopes of more stimulus measures and expectations from the rate review by the Peoples Bank of China due on Wednesday.

Triage Plus supersedes the working brand name of the test, Cxbladder Detect+. Pacific Edge has adopted the new name because it better reflects the clinical positioning of the new test in helping clinicians to triage patients presenting with hematuria2.

The major U.S. index futures are currently pointing to a higher open on Monday, with stocks likely to extend the rebound seen over the past several sessions. Easing concerns about the outlook for economy may lead to continued buying on Wall Street following the steep drop seen earlier this month.

Pacific Edge notes that Novitas, the Medicare Administrative Contractor (MAC) with responsibility for Pacific Edge’s US lab, has confirmed that it has been granted an extension to finalise or withdraw the Local Coverage Determination (LCD) ‘Genetic ...

New Zealand shares declined for a third consecutive time on Monday, pulled down by banks and healthcare stocks as U.S. jobs data dealt a further blow to the already subdued rate-cut bets from the...

Pacific Edge Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was NZD 23.91 million compared to NZD 19.62 million a year ago....

The major U.S. index futures are currently pointing to a lower open on Tuesday, with stocks likely to see further downside after ending last Friday's trading mostly lower.

Mixed sentiment prevailed in stock markets in Asia, even as the Chinese stock markets reopened after the Lunar New Year holiday on a positive note..

The major U.S. index futures are currently pointing to a modestly lower open on Friday, with stocks likely to give back ground after trending higher over the past several sessions.

Equity markets in Asia closed on a mixed note on Friday as the euphoria generated by China's surprise announcement of a 50-basis points cut in the reserve requirement for banks faded.

The major U.S. index futures are currently pointing to a higher open on Thursday, with stocks likely to move back to the upside after pulling back well off their highs late in the previous session.